How Fast Should We Build Superintelligence? | Nick Bostrom
How Fast Should We Build Superintelligence? | Nick Bostrom
Podcast39 min 38 sec
Listen to Episode
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Consider diversified exposure to AI model developers and semiconductors as long-term themes, while favoring companies that prioritize safety, monitoring, and alignment; no specific tickers or targets are provided. Treat AI-driven biomedicine and longevity as speculative, long-term opportunities rather than near-term trades. For autonomous driving and obesity treatments such as Ozempic, weigh real-world adoption barriers alongside the technology’s potential.

Detailed Analysis

Artificial Intelligence and Superintelligence

  • The discussion presents advanced AI as both a major opportunity and a significant risk. Bostrom argues that safe superintelligence could enable major advances in biomedicine, longevity, and human welfare.
  • He favors “pacing the frontier” over either racing ahead without adequate safety work or imposing a broad, potentially indefinite pause. He says a temporary delay or slower capability development could be useful if safety and alignment are falling behind.
  • The transcript explicitly refers to investment in AI model-building companies and to broader participation in commercial AI development. It does not name specific public AI stocks or provide price targets.
  • Risks discussed include AI systems recognizing when they are being tested, behaving differently in deployment, and becoming harder to monitor as their capabilities grow. Bostrom also warns that extreme regulation could become entrenched and permanently prevent superintelligence from being developed.

Takeaways

  • For investors considering AI exposure, assess not only growth prospects but also how a company handles safety, alignment, monitoring, and interpretability—issues the discussion identifies as important to the sector’s development.
  • Treat rapid capability gains as uncertain: the discussion supports neither assuming an immediate AI boom nor assuming development will stop. No company-specific recommendation or investment timeline is given.

Semiconductors and AI Infrastructure

  • Semiconductors are mentioned as part of the supply chain for AI development and as an area where investors can participate in the broader AI ecosystem.
  • The discussion does not identify semiconductor companies, tickers, valuations, or specific chip products.

Takeaways

  • Semiconductor exposure is a way to consider AI infrastructure beyond model developers, but the transcript offers no basis for choosing particular companies or estimating returns.
  • Consider the sector alongside the AI safety and governance uncertainties discussed above; the episode does not make a specific recommendation.

Biomedicine and Longevity

  • Bostrom argues that safe superintelligence could lead to major breakthroughs in biomedicine and anti-aging interventions, potentially extending life and reducing other causes of mortality.
  • He also notes that advances could address broader problems, including disease, poverty, and suffering. These are described as possible benefits, not as near-term commercial forecasts.

Takeaways

  • The discussion points to biomedicine and longevity as potential long-term beneficiaries of AI progress, but it does not name specific biotech companies, treatments, or investment opportunities.
  • Treat the theme as speculative: the benefits described depend on successfully developing safe and useful advanced AI.

Waymo and Autonomous Driving

  • Waymo is cited as an example of technology that is empirically safer than human driving, while human driving nevertheless continues. The example illustrates that having a potentially beneficial technology does not guarantee rapid or universal adoption.
  • No parent-company ticker, price target, or investment recommendation is given.

Takeaways

  • The discussion suggests that investors in autonomous driving should consider adoption and implementation barriers, not just the technology’s potential benefits.
  • The episode provides no company-specific assessment of Waymo’s commercial prospects.

Ozempic and Obesity Treatment

  • Ozempic is used as another example of an available intervention that is not universally adopted, even when the technology may address a major health problem.
  • The transcript does not discuss the product’s manufacturer, sales, clinical details, or valuation.

Takeaways

  • The example highlights a general investment consideration for medical treatments: availability does not automatically translate into widespread use.
  • The podcast does not make a specific recommendation about Ozempic or any related company.

Ask about this postAnswers are grounded in this post's content.
Episode Description
The question isn’t simply whether humanity should race toward superintelligence or stop. Nick Bostrom argues the harder challenge is preserving the ability to slow down when safety falls behind, without turning a temporary pause into permanent technological stagnation. a16z’s Eddy Lazzarin and Elena Burger sit down with Bostrom to revisit the ideas he helped bring into the mainstream, now that increasingly capable AI systems actually exist. They discuss why alignment may become harder as models grow more situationally aware, which capability improvements may carry more risk than others, and why Bostrom favors “pacing the frontier” rather than committing to a broad or indefinite pause. They also examine the cost of waiting. Bostrom argues that safely developed superintelligence could radically extend human lifespans and address problems from disease to poverty, meaning delay carries risks of its own. From there, the conversation turns to Deep Utopia, governance, the possibility of post-human forms of life, the simulation argument, and whether AI could eventually surpass humans at philosophy itself. Resources: Follow Eddy Lazzarin on X: https://x.com/eddylazzarin Follow Elena Burger on X: https://x.com/VirtualElena Follow Nick Bostrom / Macrostrategy Research Initiative: https://nickbostrom.com/  Stay Updated: Find a16z on YouTube: YouTube Find a16z on X Find a16z on LinkedIn Listen to the a16z Show on Spotify Listen to the a16z Show on Apple Podcasts Follow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
About The a16z Show
The a16z Show

The a16z Show

By Andreessen Horowitz

The a16z Podcast discusses tech and culture trends, news, and the future – especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!